The analytical performance of the OCAv3 NGS assay for detecting ERBB2 amplifications was benchmarked against the gold standard HER2 testing method, IHC-FISH, across two independent cohorts of uterine carcinomas. The gene discussed is ERBB2; the disease is uterine carcinoma.